# Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease

> **NCT04467580** · NA · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 59 (estimated)

## Conditions studied

- Crohn Disease

## Interventions

- **DIAGNOSTIC_TEST:** abdominal [18F]FDG PET/CT

## Key facts

- **NCT ID:** NCT04467580
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2023-05-02
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04467580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04467580, "Development of Inflammation and Fibrosis Index, Combining MRI and PET 18F-FDG, in Patient's With Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04467580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*